← All reports

A Phase I trial of an mRNA vaccine against Epstein-Barr Virus has been launched, which could prevent multiple sclerosis and other diseases.

HealthcareTechnologyMay 1, 2026score 0.382 posts · 2 replies across 1 instances
The thread discusses the launch of a Phase I trial for an mRNA vaccine targeting Epstein-Barr Virus (EBV), which has the potential to prevent multiple sclerosis and other diseases. The author notes a lag in preventive strategies and the urgency of addressing this gap.

Claims

A Phase I trial of an mRNA vaccine against Epstein-Barr Virus has been launched, which could prevent multiple sclerosis and other diseases.
Parent: HealthcareEntity: mRNA vaccine against Epstein-Barr VirusImpact: positiveDate: May 1, 2026Target: The effectiveness and potential impact of the mRNA vaccine against Epstein-Barr Virus in preventing multiple sclerosis and other diseases.

Source posts

@[email protected]
I want to add something else. There’s some lag time before we really start falling behind in new preventive strategies, but we are rapidly approaching it. A Phase I trial of an mRNA vaccine against EBV has just launched, and this vaccine could prevent multiple sclerosis, among other things. ClinicalTrials.gov
4 boosts · 0 favs · 1 replies · May 1, 2026
@[email protected]
There’s some lag time before the U.S. really starts falling behind in new preventive strategies, but we are rapidly approaching it. A Phase I trial of an mRNA vaccine against Epstein-Barr Virus has just launched in Australia, and this vaccine could prevent multiple sclerosis, among other things.
1 boosts · 0 favs · 1 replies · May 1, 2026